Gimv NV
Open
SectorFinanciën
44.85 0.11
Overzicht
Wijziging aandelenprijs
24u
Min
44.4
Max
44.9
Inkomsten | -81M 46M |
|---|---|
Verkoop | -43M 22M |
K/W Sectorgemiddelde | 7.778 19.1 |
EPS | 3.4 |
Dividendrendement | 5.76 |
Winstmarge | 211.533 |
Werknemers | 95 |
EBITDA | -72M 56M |
Dividendrendement Sectorgemiddelde | 5.76% 4.56% |
|---|---|
Volgende Winsten | 3 sep 2026 |
Marktkapitalisatie | 13M 1.7B |
|---|---|
Vorige openingsprijs | 44.74 |
Vorige sluitingsprijs | 44.85 |
Nieuwssentiment
By Acuity
50%
50%
177 / 438 Rangschikking in Finance
Gimv NV Grafiek
Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.
Gerelateerd nieuws
Peer Vergelijking
Prijswijziging
Gimv NV Prognose
Sentiment
By Acuity
177 / 438 Rangschikking in Financiën
Nieuwssentiment
Neutral
Volatiliteit
Onder gemiddelde
Nieuws Volume (RCV)
Boven gemiddelde
Financieel
Bedrijfskosten
Winst voor belastingen
Verkoop
Kosten van verkopen
Brutowinst op verkopen
Rente-uitgaven op schulden
EBITDA
Operationele winst
$
Over Gimv NV
Gimv NV is a private equity and venture capital firm specializing in direct and fund of funds investments. For direct investments, the firm specializes in buyouts, growth capital, middle market, debt, shareholder loans, seed, startups, early to mid-stage, late venture, public to private transactions, small and medium sized enterprises, later stage, mature, replacement capital, bridge financing, and recapitalization. Within fund of funds, it seeks to invest in venture capital and private equity funds. It seeks to invest in high performance growth companies that respond to that can speed up their internal growth through acquisitions. The firm typically invests in consumer, connected consumer, fintech; health and care; smart industries; and sustainable cities. Within consumer, it seeks to provide growth capital to emerging leaders. Within health and care platform, the firm seeks to invest in companies that can grow either organically or through a buy and build strategy. Within consumer, it focuses on consumer goods, food and beverage, healthy food, sport, convenience food, personal luxury, career, home & deco, baby & kids, pet products, retail, consumer services, media and content, travel and leisure, education, digital economy and online sectors. Within health and care sector, it focuses on life sciences, medtech, and health and care services. The firm focuses on biotech/biopharma comprising drugs, platform technologies, vaccines and diagnostic tests, preclinical, early clinical, and late clinical, medtech such as medical devices, consumables, IT and small equipment, and health and care services-based companies. It also seeks to be an active shareholder, preferably lead or co-lead in its investments. Within smart industries, it focuses on equipment, services and tools for resource efficient development and production, automotive and aerospace, both optimizing of the existing and development of new means of transport, software and services harnessing the flexibility of the cloud, smart data management and advanced c
